US government orders 2.5M more monkeypox vaccine doses from Bavarian Nordic via CMO
With the FDA giving the thumbs up for more monkeypox vaccines to come from Bavarian Nordic’s manufacturing facility in Denmark, the US government is asking for a lot more as the CDC marks the total case count north of 1,400 people.
BARDA has asked the Danish vaccine manufacturer for 2.5 million more doses of their Jynneos vaccine, a non-replicating smallpox vaccine and the only FDA-approved vaccine against monkeypox and will be going to the strategic national stockpile, or SNS.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it's free.